New discovery could help prevent the formation of infectious bacterial films on hospital equipment
Bacteria are best known as free-living single cells, but in reality their lives are much more complex. To survive in harsh environments, many species of bacteria will band together and form a biofilm–a collection of cells held together by a tough web of fibers that offers protection from all manner of threats, including antibiotics. A familiar biofilm is the dental plaque that forms on teeth between brushings, but biofilms can form almost anywhere given the right conditions.
Biofilms are a huge problem in the health care industry. When disease-causing bacteria establish a biofilm on sensitive equipment, it can be impossible to sterilize the devices, raising rates of infection and necessitating expensive replacements. So researchers look for ways to break down the defenses of biofilms to prevent them from establishing a foothold.
Now, a University of Maryland-led team has found an important link in the biofilm formation process: an enzyme that shuts down the signals that bacteria use to form a biofilm. The findings, reported in the August 24, 2015 Early Online Edition of the Proceedings of the National Academy of Sciences, have far-reaching implications for the development of new treatments, and could one day help make biofilm-related complications a distant memory.
“Bacteria form biofilms because they sense a change in their environment. They do this by generating a signaling molecule, which binds to a receptor that turns on the response,” said Mona Orr, the lead author of the study and a UMD biological sciences graduate student. “But you need a way to turn off the switch–to remove the signal when it’s no longer needed. We’ve identified the enzyme that completes the process of turning off the switch.”
The well-known switch that activates biofilm formation is a signaling molecule called Cyclic-di-GMP, also known as c-di-GMP. Many species of disease-causing bacteria use c-di-GMP to signal the formation of biofilms, including Escherichia coli, Salmonella enterica and Vibrio cholerae.
But Orr and her colleagues are the first to identify the molecule that completes the process of clearing c-di-GMP from the cell, thus ending the biofilm signaling process. The molecule is an enzyme called oligoribonuclease, and much like c-di-GMP, oligoribonuclease is also common among disease-causing bacterial species.
The team studied the process in the bacteria Pseudomonas aeruginosa, a common species known to cause infections in hospital patients. But because of the genetic and physiological similarities between P. aeruginosa and other infectious species, the researchers believe that oligoribonuclease serves the same function across a wide variety of bacteria.
“You can think of this process in terms of water filling a sink. The rate of water from the faucet is just as important as the size of the drain in determining the level of water in the sink,” said Vincent Lee, a co-author of the study and an associate professor in the UMD Department of Cell Biology and Molecular Genetics and the Maryland Pathogen Research Institute. “The level of c-di-GMP in the cell is analogous to the amount of water in the sink. Because no one knew what the drain was, our findings create a complete picture of the signaling process.”
Orr, Lee and their colleagues from the UMD Department of Chemistry and Biochemistry and Michigan State University focused their work on P. aeruginosa because it is well studied and can survive under a variety of conditions, making it notoriously difficult to control. Contact lens wearers might already be familiar with P. aeruginosa, as it commonly forms infectious, green-tinted biofilms on older lenses or those that have not been cleaned properly.
The team found that oligoribonuclease is necessary for the second of a two-step process. The first, which converts c-di-GMP into an intermediate molecule called pGpG, was already known. Orr, Lee and their colleagues have now filled in the important second step in this process: oligoribonuclease breaks apart pGpG and thus completely shuts off the signaling pathway.
The result suggests that oligoribonuclease could be used to help design new antibiotics, disinfectants, and surface treatments to control biofilms. Such measures could prevent infections and preclude the need for frequent replacement of expensive hospital equipment. Because biofilms can also form on implanted medical devices, such as pacemakers and synthetic joints, effective treatments against biofilms could eliminate the need for costly and risky replacement surgeries.
The Latest on: Biofilm
via Google News
The Latest on: Biofilm
- IU researchers develop electroceutical dressing to disrupt bacterial biofilms on May 19, 2019 at 10:56 pm
Work conducted in the laboratories of the Indiana Center for Regenerative Medicine and Engineering, Chandan Sen, PhD and Sashwati Roy, PhD has led to the development of a dressing that uses an ... […]
- Op-Ed: Electrically charged dressings beat bacteria on May 19, 2019 at 12:09 pm
The theory is that bacteria send a chemically generated electrical signal like a reflex action in response to certain stimuli, like antibiotics, and the biofilm responds according to the electrical ... […]
- Electricity is Being Used to Treat Wound Infections on May 19, 2019 at 7:20 am
The novel work has seen positive results in the treatment of bacterial biofilm infections. Bacterial biofilms are a type of bacteria that develop on wounds after burns or post-surgical infections ... […]
- Electric field-based dressing helps heal wound infections on May 17, 2019 at 2:44 pm
Scientists have developed a dressing that uses an electric field to disrupt biofilm infection in wounds. Researchers at Indiana University School of Medicine have found a way to charge up the fight ... […]
- BioTimer assay as complementary method to vortex-sonication-vortex technique for the microbiological diagnosis of implant associated infections on May 17, 2019 at 2:24 am
On the other hand, also VSVM, allowing to identify microbial genera and species, possesses, anyhow, limits already reported such as not complete biofilm detachment, under-estimated microbial number ... […]
- The future of dental cleaning? Biofilm-busting micro-robots impress in precision cleaning trials on April 25, 2019 at 9:01 pm
An army of tiny robots scuttling about inside your mouth cleaning your teeth. It's a disquieting thought, and yet it might be one of the most effective ways to deal with the sticky bacterial biofilms ... […]
- New dispersion method to effectively kill biofilm bacteria could improve wound care on April 23, 2019 at 11:40 am
Researchers have developed a method to treat bacterial infections which could result in better wound care. Biofilms are a structured community of bacterial cells that are adherent to inert or living ... […]
- New dispersion method to effectively kill biofilm bacteria could improve wound care on April 23, 2019 at 7:46 am
Researchers at Binghamton University, State University of New York have developed a method to treat bacterial infections which could result in better wound care. Biofilms are a structured community of ... […]
- IPO Watch: Biofilm bug fighter Next Science shut its IPO after raising $35 million in three days on April 9, 2019 at 1:06 pm
Next Science, which is set to list on the ASX at the end of this month, is further down the road than many biotech companies that seek to go public. For one thing, it has already has four products ... […]
- National consortium formed to help companies combat bacteria on February 26, 2019 at 4:56 am
A biofilm is a thin, slimy and sticky layer that houses a community of bacteria and other micro-organisms on any surface. As the harmful bacteria are located close to one another, biofilms can ... […]
via Bing News